Vitamin D supplementation on anemia markers and the impact on PTH in patients with chronic kidney disease

Authors

DOI:

https://doi.org/10.33448/rsd-v10i9.17752

Keywords:

Vitamin D Supplementation; Cholecalciferol; Erythropoietin; Hemoglobin; Anemia; Chronic kidney disease.

Abstract

Chronic Kidney Disease (CKD) is an injury that causes progressive impairment of exocrine and endocrine renal functions. A very common complication is anemia, caused by reduced erythropoietin production, iron deficiency and inflammation. Evidence demonstrates that vitamin D has effects on anemia of inflammation, through the increase in erythrocytes and decrease in pro-inflammatory cytokines. This study aims to review the effects of vitamin D supplementation on 25(OH)D2 concentrations, on anemia markers and on PTH levels. This is an integrative review carried out through the search and selection of original publications, in english and portuguese, indexed in PubMed, Web of Science and Science Direct databases belonging to the 2010-2020 range. The results pointed to 25(OH)D2 concentrations compatible with normality after vitamin D supplementation. In five studies, there was no change in hemoglobin and PTH levels, and in four studies there was a reduction in the dose of EPO or erythroid stimulating agent, attributing such effect on the role of calcitriol as a substrate for bone marrow erythropoietic cells. The study concluded that vitamin D supplementation had beneficial effects for correction of 25(OH)D2 deficiency, however, it reinforces the controversy about the behavior of vitamin D on the improvement of anemia markers and PTH levels in patients with DRC. Therefore, it is suggested that the beneficial effect of vitamin D on anemia in renal patients may be independent of PTH suppression.

Author Biography

Letícya Thaís Mendes Viana, Universidade Federal do Piauí

Graduação em Nutrição pela Universidade Federal do Piauí (2017). Especialização em Nutrição Clínica e Funcional pelo Centro Universitário Santo Agostinho (2019). Atualmente, mestranda em Alimentos e Nutrição (PPGAN/UFPI 2019-2021).  

References

Agarwal, G., Hirachan, P., Gelfond, J., Fanti, P., Hura, C., & Bansal, S. (2016). Treatment with ergocalciferol does not improve the rate of use and hospitalization of erythropoietin in hemodialysis patients. BMC Nephrology, 17(144).

Agarwal, A. K. (2021). Iron metabolism and management: focus on chronic kidney disease. Kidney International Supplements, 11(1), 46-58.

Al-shaer, O. S., Behiry, E. G., Ahmed, A. A., & Moustafa, H. (2020). Association between the genetic variant of the vitamin D receptor (FokI) rs2228570 and iron profile in hemodialysis patients. Molecular Biology Reports, 47(1), 545-53.

Arabi, S. M., Ranjbar, G., Bahrami, L. S., Vafa, M., & Norouzy, A. (2020). The effect of vitamin D supplementation on the concentration of hemoglobin: a systematic review and meta-analysis. Nutrition, 9(11).

Bacchetta, J., Zaritsky, J. J., Mar, J. L., Chun, R. F., Lisse, T. S., Zavala, K., & Hewison, M. (2014). Vitamin D Iron Regulatory Hepcidin Suppression. Journal of the American Society of Nephrology, 25(3), 564-72.

Bailie, G. R., Larkina, M., Goodkin, D. A., Li, Y., Pisoni, R. L., Bieber, B., & Robinson, B. M. (2015). Data from the study of standards of practice and results of dialysis validate an association between high doses of iron intravenous and mortality. Kidney International, 87(1), 162-68.

Bashardoust, B., Zakeri, A., Fouladi, N., Izadi, Z., & Hosseini, F. (2018). Effect of ergocalciferol treatment on bone metabolism and parathyroid hormone indices in hemodialysis patients. Iranian Journal of Kidney Diseases, 12(6), 359-63.

Begum, S., & Latunde-Dada, G.O. (2019). Inflammation anemia with emphasis on chronic kidney disease. Nutrients, 11(10), 2424.

Bhan, I., Dobens, D., Tamez, H., Deferio, J. J., Li, Y. C., Warren, S., & Thadhani, R. (2015). Nutritional supplementation of vitamin D on dialysis: a study randomized. Clinical Journal American Society of Nephrology, 10(4), 611-619.

Bucharles, S., Barberato, S. H., Stinghen, A. E., Gruber, B., Piekala, L., Dambiski, A. C., & Pecoits-Filho, R. (2012). Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialys is patient swith out hyperparathyroidism. Journal Renal Nutrtion, 22, 584-91.

Bueno, C. S., & Frizzo, M. N. (2014). Anemia na doença renal crônica em hospital da região noroeste do estado do Rio Grande do Sul. Brazilian Journal of Nephrology, 36(3), 304-14.

Cuspiti, A., Vigo, V., Baronti, M. E., D’Alessandro, C., Ghiadoni, L., & Egidi, M. F. (2015). Vitamin D status and cholecalciferol supplementation in patients with chronic kidney disease: an Italian cohort report. International Journal Nephrology Renovascular Disease, 8, 151-157.

Daimon, M., Fujita, T., Murabayashi, M., Mizushiri, S., Murakami, H., Nishiya, Y., & Ihara K. (2020). Exacerbation of hyperparathyroidism, secondary to reduced renal function, in individuals with vitamin D deficiency. Frontiers in Medicine, 7, 221.

Duque, S.J., Elias, R.M., & Moysés, R.M.A. (2020). Parathyroid hormone: an uremic toxin. Toxins (Basel), 12(3), 189.

Goicoechea, M., Vazquez, M. I., Ruiz, M. A., Gomez-Campdera, F., Perez-Garcia, R., & Valderrabano, F. (1998). Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron, 78(1), 23-27.

Kumar, V. A., Kujubu, D. A., Sim, J. J., Rasgon, A. S., & Yang, O. S. (2011). Vitamin D and recombinant supplementation use of human erythropoietin in vitamins Hemodialysis patients with D deficiency. Journal Nephrology, 24(1), 98-105.

Kuo, K. L., Hung, S. C., Lin, Y. P., Tang, C. F., Lee, T. S., Lin, P. C., & Tarng, D. C. (2012). Intravenous supplementation of ferric chloride with hexahydrate Induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. PLoS One, 7(12).

Lima, M. A. F. (2017). Status de Vitamina D e Fatores Associados em Indivíduos Submetidos a Transplante Renal: Um Estudo Longitudinal (Dissertação de Mestrado). Universidade Federal do Rio Grande do Norte, Natal.

López-Ramiro, E., Rubert, M., González-Parra, E., Mahillo, I., & De la Piedra, C. (2017). Correlation between 25-hydroxy-vitamin D levels and the degree of anemia in patients with chronic kidney disease. American Journal of Clinical and Experimental Medicine, 5(4), 151-56.

Madu, A. J., & Ughasoro, M. D. (2017). Chronic disease anemia: an in-depth review. Medical Principles and Practice, 26(1), 1-9.

Masoud, M. S., Alokail, M. S., Yakout, S. M., Khattak, M. N. K., Alrehaili, M. M., Wani, K., & Al-Daghri, N. M. (2018). Vitamin D Supplementation Modestly Reduces Serum Indices Arab teenagers ironing. Nutrients, 10(12).

Matias, P. J., Jorge, C., Ferreira, C., Borges, M., Aires, I., Amaral, T., & Ferreira, A. (2010). Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation and size parameters cardiac. Clinical Journal American Society of Nephrology, 5(5), 905–911.

Miskulin, D. C., Majchrzak, K., Tighiouart, H., Muther, R. S., Kapoian, T., Johnson, D. D. S., & Weiner, D. E. (2016). Ergocalciferol supplementation in patients in hemodialysis with vitamin D deficiency: a trial randomized clinical trial. Journal American Society of Nephrology, 27(6), 1801-1810.

Mowbray, P. K., Wilkinson, A., & Tse, H. H. M. (2014). An integrative review of employee voice: identifying a common conceptualization and research agenda. International Journal of Management Reviews, 17(3).

Naini, A. E., Hadaiati, Z. P., Gholami, D., Pezeshki, A. H., & Moinzadeh, F. (2015). The effect of vitamin D administration on the treatment of anemia in patients with terminal renal disease with vitamin D deficiency in hemodialysis: a double-blind, placebo-controlled clinical trial. Journal of Research in Medical Sciences, 20(8), 745-50.

Nand, N., & Mittal, R. (2017). Evaluation of Effect of Vitamin D Deficiency on Anemia and Erythropoietin Hyporesponsiveness in Patients of Chronic Kidney Disease. Journal of the Association of Physicians of India, 65(2), 38-42.

Neves, P. D. M. M., Sesso, R. C. C., Thomé, F. S., Lugon, J. R., & Nascimento, M. M. (2021) Inquérito brasileiro de diálise 2019. Brazilian Journal of Nephrology, 43(1).

Obi, Y., Yamaguchi, S., Hamano, T., Sakaguchi, Y., Shimomura, A., Namba-Hamano, T., & Isaka, Y. (2020). Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial. Scientific Reports, 10(1), 15500.

Oliveira, W. V. J., Zica, C. L. A., Gouveia, I. P. P., Vasconcelos, M. O., Oliveira, R. R., & Oliveira, T. S. (2019). Anemia de doença crônica na doença renal crônica. Revista Conexão Ci, 14(2), 57-65.

Patel, N. M., Gutiérrez, O. M., Andress, D. L., Coyne, D. W., Levin, A., & Wolf, M. (2010). Vitamin D deficiency and anemia in chronic kidney disease precocious. Kidney International, 77(8), 715-720.

Porter, A., Gilmartin, C., Srisakul, U., Arruda, J., & Akkina, S. (2013). Prevalence of vitamin D 25-OH deficiency in a population of hemodialysis patients and the effectiveness of a supplementation regimen oral ergocalciferol. American Journal Nephrology, 37(6), 568-574.

Riccio, E., Sabbatini, M., Bruzzese, D., Capuano, I., Migliaccio, S., Andreucci, M., & Pisani, A. (2015). Effect of Paricalcitol vs Calcitriol on hemoglobin levels in patients with chronic kidney disease: a randomized study. Plos One, 10(3).

Sah, S. K., & Adhikary, L. P. (2019). Prevalence of abnormal serum 25-hydroxyvitamin D and its association with hemoglobin level in patients with pre-dialysis CKD: one cross-sectional study of the Himalayan country. BMC Nephrology, 20(267).

Sim, J. J., Lac, P. T., Liu, E. A., Meguerditchian, S. O., Kumar, V. A., Kujubu, D. A., & Rasgon, S. A. (2010). Vitamin D deficiency and anemia: a cross-sectional study. Annals of Hematology, 89(5), 447-52.

Smith, E. M., & Tangpricha, V. (2015). Vitamin D and Anemia: Insights into an Emerging Association. Current Opinion in Endocrinology, Diabetes and Obesity, 22(6), 432-38.

Sonkar, S. K., Singh, H. P., Sonkar, G. K., & Pandey, S. (2018). Association of vitamin D and secondary hyperparathyroidism with anemia in diabetic kidney disease. Journal Family Medicine Primary Care, 7(4), 815-818.

Zughaier, S. M., Alvarez, J. A., Sloan, J. H., Konrad, R. J., & Tangpricha, V. (2014). The role of vitamin D in regulating their on-hepcidin-ferroportinax is in monocytes. Journal of Clinical and Translational Endocrinology, 1(1).

Downloads

Published

02/08/2021

How to Cite

VIANA, L. T. M. .; RODRIGUES, L. L. .; SILVA, J. do N.; SOUSA, M. M. D. de .; ANDRADE, F. S. .; FREITAS, B. de J. e S. de A. Vitamin D supplementation on anemia markers and the impact on PTH in patients with chronic kidney disease. Research, Society and Development, [S. l.], v. 10, n. 9, p. e53310917752, 2021. DOI: 10.33448/rsd-v10i9.17752. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/17752. Acesso em: 26 sep. 2021.

Issue

Section

Health Sciences